The reimbursement model for remote patient monitoring needs to evolve as it may be holding providers back from investing in these programs, according to panelists at the MedCity INVEST Digital Health conference. Key issues with the structure as it stands now include the fact that there are too many gray areas that result in claims denials.
The volume of deals in the health services sector hit a quarterly record-high of 426 deals in Q1 2021, up 21% from 352 deals in the fourth quarter of 2020. Regulatory shifts, changes in care delivery and the rise of non-traditional healthcare companies are all driving the trend.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Healthcare is in the midst of a digital revolution, unlike anything the industry has experienced before. But, according to CHIME CEO Russell Branzell, the growing dependence on technology for patient care and remote work is raising concerns related to cyberattacks.
There is nothing more convincing that someone citing research, and yet we often don’t know if what’s being cited is any good. Research can be bad if it’s poorly conducted or if the wrong evaluative method was used to answer the question. The methods we use in health care are often quite limited, especially when […]
The bottom line of PricewaterhouseCoopers’ Health Research Institute report on innovation in the medtech industry can be summed up as follows: “The value of a device is no longer solely in the product itself.” While clinical efficacy is a must, the true value in medtech today is a company’s ability to provide information, services, and […]
At Advamed 2013, industry leaders met and discussed how startups and innovation can beat the odds without much chance of gaining venture capital at an extremely early stage. Here are realistic options for medical device companies looking to fundraise early rounds without venture. 1. Raise enough for each round. Remember that truism from Mark Twain […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Cost effectiveness and outcomes drive value for payers, Cigna‘s Chief Medical Officer Alan Muney said. While some medical device companies assume an FDA approval will mean a definite reimbursement nod from payers, these two forces drive a sometimes wrongheaded “gap of hopefulness” for the industry. (See his discussion of why device companies need to think […]
At a panel on moving from volume to value at Advamed 2013, Dr. Clifford Belden of the Dartmouth-Hitchcock Medical Center gave an example of exactly what medical device company value means to accountable care organizations. He compared four devices the ACO considered (or is still considering) for purchase in 2013, then said which ones they […]
Medtech Women will focus on value in healthcare at its annual Vision conference on Sept. 10 in Menlo Park, Calif. According to the organization’s website, the group brings together medtech’s “business leaders, financial investors, researchers, physicians and experts in new product commercialization.” “A key pillar of the MedtechVision conference is fostering a forum that provokes […]